[Silencing CD46 and DSG2 in Host A549 Cells Inhibits Entry of Human Adenovirus Type 3 and Type 7 and Reduces Interleukin-8 Release]

Overview

Journal Nan Fang Yi Ke Da Xue Xue Bao

Specialty General Medicine

Date 2022 Oct 10

PMID 36210707

Authors

Z Yang

Y Fu

L Ren

S Chen

E Liu

N Zang

Affiliations

Soon will be listed here.

Abstract

Objective: To investigate the effect of silencing CD46 and desmoglein 2 (DSG2) in host A549 cells on the entry of human adenovirus type 3 (HAdV-3) and type 7 (HAdV-7) and host cell secretion of inflammatory cytokines.

Methods: RNA interference technique was use to silence the expression of CD46 or DSG2 in human epithelial alveolar A549 cells as the host cells of HAdV-3 or HAdV-7. The binding of the viruses with CD46 and DSG2 were observed with immunofluorescence staining at 0.5 and 1 h after viral infection. The viral load in the host cells was determined with qRT-PCR, and IL-8 secretion level was measured using ELISA.

Results: In infected A549 cells, immunofluorescent staining revealed colocalization of HAdV-3 and HAdV-37 with their receptors CD46 and DSG2 at 0.5 h and 2 h after infection, and the copy number of the viruses increased progressively after the infection in a time-dependent manner. In A549 cells with CD46 silencing, the virus titers were significantly lower at 2, 6, 12 and 24 h postinfection in comparison with the cells without gene silencing; the virus titers were also significantly decreased in the cells with DSG2 silencing. The secretion level of IL-8 increased significantly in A549 cells without siRNA transfection following infection with HAdV-3 and HAdV-7 ( < 0.0001), but decreased significantly in cells with CD46 and DSG2 silencing ( < 0.0001).

Conclusion: HAdV-3 and HAdV-7 enter host cells by binding to their receptors CD46 and DSG2, and virus titer and cytokines release increase with infection time. Silencing CD46 and DSG2 can inhibit virus entry and cytokine IL-8 production in host cells.

Citing Articles

Chimeric Ad5/35 oncolytic adenovirus overcome preexisting neutralizing antibodies and enhance tumor targeting efficiency.

Dai Z, Si Y, Xiong S, Li Y, Ye J, Gao Q Cancer Gene Ther. 2025; .

PMID: 40057574 DOI: 10.1038/s41417-025-00884-x.

References

Sun X, Liu X, Feng L . [Progress in the Development of Animal Models Supporting Human Adenovirus Infection]. Bing Du Xue Bao. 2018; 32(6):810-6. View

Yang C, Wang Y, He J, Yan W, Jiang H, Chen Q . Lianhua-Qingwen Displays Antiviral and Anti-Inflammatory Activity and Synergistic Effects with Oseltamivir against Influenza B Virus Infection in the Mouse Model. Evid Based Complement Alternat Med. 2020; 2020:3196375. PMC: 7293728. DOI: 10.1155/2020/3196375. View

Colpitts C, Schang L . A small molecule inhibits virion attachment to heparan sulfate- or sialic acid-containing glycans. J Virol. 2014; 88(14):7806-17. PMC: 4097786. DOI: 10.1128/JVI.00896-14. View

Persson B, John L, Rafie K, Strebl M, Frangsmyr L, Ballmann M . Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46. Proc Natl Acad Sci U S A. 2021; 118(3). PMC: 7826407. DOI: 10.1073/pnas.2020732118. View

Casasnovas J . Virus-receptor interactions and receptor-mediated virus entry into host cells. Subcell Biochem. 2013; 68:441-66. PMC: 7122110. DOI: 10.1007/978-94-007-6552-8_15. View

Heim A, Ebnet C, Harste G, Pring-Akerblom P . Rapid and quantitative detection of human adenovirus DNA by real-time PCR. J Med Virol. 2003; 70(2):228-39. DOI: 10.1002/jmv.10382. View

Lu X, Trujillo-Lopez E, Lott L, Erdman D . Quantitative real-time PCR assay panel for detection and type-specific identification of epidemic respiratory human adenoviruses. J Clin Microbiol. 2013; 51(4):1089-93. PMC: 3666809. DOI: 10.1128/JCM.03297-12. View

Veenstra M, Williams D, Calderon T, Anastos K, Morgello S, Berman J . Frontline Science: CXCR7 mediates CD14CD16 monocyte transmigration across the blood brain barrier: a potential therapeutic target for NeuroAIDS. J Leukoc Biol. 2017; 102(5):1173-1185. PMC: 5636044. DOI: 10.1189/jlb.3HI0517-167R. View

Trinh H, Lesage G, Chennamparampil V, Vollenweider B, Burckhardt C, Schauer S . Avidity binding of human adenovirus serotypes 3 and 7 to the membrane cofactor CD46 triggers infection. J Virol. 2011; 86(3):1623-37. PMC: 3264387. DOI: 10.1128/JVI.06181-11. View

10.

Zhong H, Dong X . Analysis of Clinical Characteristics and Risk Factors of Severe Adenovirus Pneumonia in Children. Front Pediatr. 2021; 9:566797. PMC: 8546294. DOI: 10.3389/fped.2021.566797. View

11.

Ko J, Woo H, Oh H, Moon S, Choi J, Lim J . Ongoing outbreak of human adenovirus-associated acute respiratory illness in the Republic of Korea military, 2013 to 2018. Korean J Intern Med. 2019; 36(1):205-213. PMC: 7820655. DOI: 10.3904/kjim.2019.092. View

12.

Yang M, Yang C, Tao Y, Tang J, Huang Q, Guo W . Combination therapy with F5/35 fiber chimeric conditionally replicative adenoviruses expressing IL-24 enhances the antitumor effect of temozolomide against melanoma. Cancer Med. 2018; 7(12):5928-5942. PMC: 6308089. DOI: 10.1002/cam4.1843. View

13.

Chikhalya A, Dittmann M, Zheng Y, Sohn S, Rice C, Hearing P . Human IFIT3 Protein Induces Interferon Signaling and Inhibits Adenovirus Immediate Early Gene Expression. mBio. 2021; 12(6):e0282921. PMC: 8561380. DOI: 10.1128/mBio.02829-21. View

14.

Dai H, Xi H, Huang L, Yuan Z, Liao Y, Tang Y . Molecular Epidemiology and Clinical Features Analysis of Respiratory Adenovirus Infections Reveals Correlations between Genotype, Inflammatory Biomarkers, and Disease Severity. Biomed Res Int. 2020; 2020:4357910. PMC: 7596535. DOI: 10.1155/2020/4357910. View

15.

Eckstein A, Grossl T, Geisler A, Wang X, Pinkert S, Pozzuto T . Inhibition of adenovirus infections by siRNA-mediated silencing of early and late adenoviral gene functions. Antiviral Res. 2010; 88(1):86-94. DOI: 10.1016/j.antiviral.2010.08.002. View

16.

Kanegae Y, Makimura M, Saito I . A simple and efficient method for purification of infectious recombinant adenovirus. Jpn J Med Sci Biol. 1994; 47(3):157-66. DOI: 10.7883/yoken1952.47.157. View

17.

Spjut S, Qian W, Bauer J, Storm R, Frangsmyr L, Stehle T . A potent trivalent sialic acid inhibitor of adenovirus type 37 infection of human corneal cells. Angew Chem Int Ed Engl. 2011; 50(29):6519-21. PMC: 3210828. DOI: 10.1002/anie.201101559. View

18.

Chu V, Simon E, Lu X, Rockwell P, Abedi G, Gardner C . Outbreak of Acute Respiratory Illness Associated With Human Adenovirus Type 4 at the United States Coast Guard Academy, 2019. J Infect Dis. 2021; 225(1):55-64. DOI: 10.1093/infdis/jiab322. View

19.

Li X, Zhou Z, Liu W, Fan Y, Luo Y, Li K . Chinese tree shrew: a permissive model for in vitro and in vivo replication of human adenovirus species B. Emerg Microbes Infect. 2021; 10(1):424-438. PMC: 7971223. DOI: 10.1080/22221751.2021.1895679. View

20.

Pfortmueller C, Barbani M, Schefold J, Hage E, Heim A, Zimmerli S . Severe acute respiratory distress syndrome (ARDS) induced by human adenovirus B21: Report on 2 cases and literature review. J Crit Care. 2019; 51:99-104. PMC: 7172394. DOI: 10.1016/j.jcrc.2019.02.019. View